Food And Drug Administration-Acute Coronary Syndrome-New Blood Thinner-Healthday News

FDA Panel Votes Against New Use for Blood Thinner Xarelto

WEDNESDAY, May 23 (Healthday News) -- An advisory panel to the U.S. Food and Drug Administration on Wednesday voted against a new use of a new blood thinner, Xarelto, to cut the risk of potentially lethal clots in people with acute coronary syndrome. read more..

source:http://yhoo.it/MsNMrW

Food And Drug Administration-New Blood Thinner-Fatal Blood Clots-Heart Patients

New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA

MONDAY, May 21 (Healthday News) -- The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found. read more..

source:http://yhoo.it/JNt0WN